On this episode of the Business of Biotech, we're going deep with Glympse Bio CEO Dr. Caroline Loew to explore the possibilities and implications of the in-vivo, bioengineered, tunable sensors the company is developing for diagnostic and prognostic purposes in protease-mediates diseases. Listen now and subscribe so you never miss an episode.
We all know the phase-gate approach to medical device development is cumbersome and slow — the exact opposite of what’s needed for products essential to critical treatment. The good news is that there are ways to make dramatic improvements to the efficiency of the product development process while maintaining project phase controls.
RFID technology helps manufacturers relying on repeat sales of consumable components to combat threats to profitability and performance while ensuring superior operability for their end-use customers. This white paper further discusses the benefits of RFID technology and presents five ways that it may be used to optimize consumables programs.